420 related articles for article (PubMed ID: 17191054)
1. Anti-SSA/Ro antibody as a risk factor for fluorouracil-induced drug eruptions showing acral erythema and discoid-lupus-erythematosus-like lesions.
Adachi A; Nagai H; Horikawa T
Dermatology; 2007; 214(1):85-8. PubMed ID: 17191054
[TBL] [Abstract][Full Text] [Related]
2. Discoid lupus erythematosus (DLE)-like lesion induced by uracil-tegafur (UFT).
Yoshimasu T; Hiroi A; Uede K; Furukawa F
Eur J Dermatol; 2001; 11(1):54-7. PubMed ID: 11174141
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-induced cutaneous lupus erythematosus in patients with serum anti-SSA/Ro antibody.
Adachi A; Horikawa T
J Dermatol; 2007 Jul; 34(7):473-6. PubMed ID: 17584326
[TBL] [Abstract][Full Text] [Related]
4. The autoantibody response to Ro/SSA in cutaneous lupus erythematosus.
Lee LA; Roberts CM; Frank MB; McCubbin VR; Reichlin M
Arch Dermatol; 1994 Oct; 130(10):1262-8. PubMed ID: 7944507
[TBL] [Abstract][Full Text] [Related]
5. Discoid lupus erythematosus (DLE)-like lesions induced by capecitabine.
Merlin F; Prochilo T; Kildani B; Lombardi C; Pasolini G; Bonetti F; Beretta GD
Int J Colorectal Dis; 2008 Jul; 23(7):715-6. PubMed ID: 18330579
[No Abstract] [Full Text] [Related]
6. Indirect immunofluorescence on HEp-2000 substrate is a sensitive method for detecting anti-Ro/SSA antibodies in patients with lupus erythematosus and/or photosensitivity.
Cozzani E; Drosera M; Siccardi M; Babbini G; Parodi A
J Rheumatol; 2008 Jul; 35(7):1320-2. PubMed ID: 18528967
[TBL] [Abstract][Full Text] [Related]
7. [Adult discoid lupus erythematosus].
Khelifa E; Benmously R; Fenniche S; Marrak H; Zghal M; Mokhtar I
Tunis Med; 2007 Mar; 85(3):205-8. PubMed ID: 17668574
[TBL] [Abstract][Full Text] [Related]
8. Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus.
Srivastava M; Rencic A; Diglio G; Santana H; Bonitz P; Watson R; Ha E; Anhalt GJ; Provost TT; Nousari CH
Arch Dermatol; 2003 Jan; 139(1):45-9. PubMed ID: 12533163
[TBL] [Abstract][Full Text] [Related]
9. Systemic sclerosis with unusual panniculitis and overlying discoid lupus erythematosus-like lesions.
Oka H; Tanikawa A; Matsuda F; Tanaka M; Nishikawa T
J Dtsch Dermatol Ges; 2005 Aug; 3(8):627-9. PubMed ID: 16033482
[TBL] [Abstract][Full Text] [Related]
10. Acral erythema with oral methotrexate in a child.
Varela CR; McNamara J; Antaya RJ
Pediatr Dermatol; 2007; 24(5):541-6. PubMed ID: 17958806
[TBL] [Abstract][Full Text] [Related]
11. Anti-annexin 1 antibodies: a new diagnostic marker in the serum of patients with discoid lupus erythematosus.
Kretz CC; Norpo M; Abeler-Dörner L; Linke B; Haust M; Edler L; Krammer PH; Kuhn A
Exp Dermatol; 2010 Oct; 19(10):919-21. PubMed ID: 20701627
[TBL] [Abstract][Full Text] [Related]
12. Discoid lupus erythematosus in an infant.
Badri T; Khaddar RK; Bouraoui S; Mokni M; Cherif F; Dhahri AB
Dermatol Online J; 2005 Dec; 11(3):38. PubMed ID: 16409934
[TBL] [Abstract][Full Text] [Related]
13. [Chemotherapy-induced acral erythema: a clinical and histopathologic study of 44 cases].
Hueso L; Sanmartín O; Nagore E; Botella-Estrada R; Requena C; Llombart B; Serra-Guillén C; Alfaro-Rubio A; Guillén C
Actas Dermosifiliogr; 2008 May; 99(4):281-90. PubMed ID: 18394404
[TBL] [Abstract][Full Text] [Related]
14. Macrophage marker 27E10 on human keratinocytes helps to differentiate discoid lupus erythematosus and Jessner's lymphocytic infiltration of the skin.
Kunz M; Henseleit-Walter U; Sorg C; Kolde G
Eur J Dermatol; 1999 Mar; 9(2):107-10. PubMed ID: 10066957
[TBL] [Abstract][Full Text] [Related]
15. [Lichen planus/lupus erythematosus overlap syndrome].
Cecchi R; Brunetti L; Troiano G; Pavesi M; Giomi A
G Ital Dermatol Venereol; 1990 Aug; 125(7-8):345-8. PubMed ID: 2289817
[TBL] [Abstract][Full Text] [Related]
16. Direct immunofluorescence for the study of cutaneous drug eruptions.
Gibson LE; van Hale HM; Schroeter AL
Acta Derm Venereol; 1986; 66(1):39-44. PubMed ID: 2424213
[TBL] [Abstract][Full Text] [Related]
17. A serology-based approach combined with clinical examination of 125 Ro/SSA-positive patients to define incidence and prevalence of subacute cutaneous lupus erythematosus.
Popovic K; Nyberg F; Wahren-Herlenius M; Nyberg F
Arthritis Rheum; 2007 Jan; 56(1):255-64. PubMed ID: 17195229
[TBL] [Abstract][Full Text] [Related]
18. Atypical moles in a patient undergoing chemotherapy with oral 5-fluorouracil prodrug.
Fukushima S; Hatta N
Br J Dermatol; 2004 Sep; 151(3):698-700. PubMed ID: 15377362
[TBL] [Abstract][Full Text] [Related]
19. Discoid Lupus Erythematosus Lesions Associated with Systemic Fluorouracil Agents: A Case Report and Review.
Cohen PR
Cureus; 2020 Apr; 12(4):e7828. PubMed ID: 32467803
[TBL] [Abstract][Full Text] [Related]
20. Report of a case of discoid lupus erythematosus localised to the oral cavity: immunofluorescence findings.
Serpico R; Pannone G; Santoro A; Mezza E; Piccolo S; Esposito V; Busciolano M; Ciavarella D; Lo Muzio L; Bufo P
Int J Immunopathol Pharmacol; 2007; 20(3):651-3. PubMed ID: 17880780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
